HTLV-I Tax-Mediated Inactivation of Cell Cycle Checkpoints and DNA Repair Pathways Contribute to Cellular

Christophe Nicot1

  • 1Department of Pathology and Laboratory Medicine, Center for Viral Oncology, University of Kansas Medical Center, USA.

Journal of Cancer Sciences
|February 3, 2016
PubMed

Insights

Human T-cell leukemia virus type 1 (HTLV-I) uses its Tax protein to disrupt cell cycle checkpoints and DNA repair, leading to genetic mutations and cancer. This "Random Mutagenesis" model better explains HTLV-I

Area of Science:

  • Virology
  • Oncology
  • Molecular Biology

Background:

  • Most oncogenic retroviruses cause cellular transformation via proto-oncogene capture or insertional mutagenesis.
  • Human T-cell leukemia virus type 1 (HTLV-I) is a transactivating retrovirus, with its Tax protein thought to drive transformation.
  • However, the low transformation frequency (<5%) challenges the sufficiency of Tax-mediated transactivation alone.

Purpose of the Study:

  • To review current understanding and recent discoveries on the critical functions of Tax in HTLV-I-mediated cellular transformation.
  • To highlight Tax's role in overriding cell cycle checkpoints and deregulating cellular division.
  • To explore Tax's impact on DNA damage, genome instability, and repair pathways.

Main Methods:

  • Review of existing literature on HTLV-I, Tax protein functions, and cellular transformation mechanisms.
  • Analysis of experimental evidence regarding Tax's effects on cell cycle regulation and DNA repair.
  • Comparison of different models of viral oncogenesis.

Main Results:

  • HTLV-I Tax overrides cell cycle checkpoints and deregulates cell division.
  • Tax expression increases DNA damage and genome instability.
  • Tax inhibits DNA repair pathways and promotes error-prone repair or checkpoint bypass, facilitating mutation accumulation.

Conclusions:

  • Tax-mediated transactivation alone is insufficient for HTLV-I's low transformation frequency.
  • Tax's ability to induce DNA damage, inhibit repair, and deregulate cell division supports a 'Random Mutagenesis' model for HTLV-I oncogenesis.
  • This model better characterizes the oncogenic activities of HTLV-I.

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

5.8K